Long-term Arg therapy has been shown to prevent or delay the onset of T2DM and maintain long-lasting effects on diabetes incidence, insulin secretion, oxidative stress, and endothelial function in high-risk individuals [49]. This evidence concerns the gene INS and diabetes mellitus.